Curanex Pharmaceuticals Inc. announced that Dominari Securities LLC has exercised in full the over-allotment option and purchased an additional 562,500 shares of common stock at the IPO price of $4.00 per share, raising an additional $2,250,000 for a total of $17,250,000 in gross proceeds. The offering was led by Dominari Securities LLC, with Pacific Century Securities LLC and Revere Securities LLC as co-underwriters. The Company is dedicated to discovering and developing botanical drugs for inflammatory diseases, with a lead candidate, Phyto-N, showing promise in treating various inflammatory diseases. For more information, visit the Company’s website.

Read more at GlobeNewswire: Curanex Pharmaceuticals Inc. Announces Exercise of the